These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6499359)

  • 1. Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer.
    Lønning E; Kvinnsland S; Bakke OM
    Clin Pharmacol Ther; 1984 Dec; 36(6):796-802. PubMed ID: 6499359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.
    Lundgren S; Kvinnsland S; Utaaker E; Bakke O; Ueland PM
    Cancer Chemother Pharmacol; 1986; 18(3):270-5. PubMed ID: 2948732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglutethimide as an inducer of microsomal enzymes. Part 1: Pharmacological aspects.
    Kvinssland S; Lønning PE; Ueland PM
    Breast Cancer Res Treat; 1986; 7 Suppl():S73-6. PubMed ID: 2943339
    [No Abstract]   [Full Text] [Related]  

  • 4. Aminoglutethimide enzyme induction: pharmacological and endocrinological implications.
    Lønning PE
    Cancer Chemother Pharmacol; 1990; 26(4):241-4. PubMed ID: 2369789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.
    Denlinger CL; Stryker KK; Slusher LB; Vesell ES
    Clin Pharmacol Ther; 1987 May; 41(5):522-30. PubMed ID: 3568537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglutethimide and warfarin. A new important drug interaction.
    Lønning PE; Kvinnsland S; Jahren G
    Cancer Chemother Pharmacol; 1984; 12(1):10-2. PubMed ID: 6690067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine impairs the elimination of theophylline and antipyrine.
    Roberts RK; Grice J; Wood L; Petroff V; McGuffie C
    Gastroenterology; 1981 Jul; 81(1):19-21. PubMed ID: 7239117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
    Teunissen MW; De Leede LG; Boeijinga JK; Breimer DD
    J Pharmacol Exp Ther; 1985 Jun; 233(3):770-5. PubMed ID: 4009489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large theophylline requirements due to high theophylline clearance: verification by the antipyrine test.
    Blyden GT; LeDuc BW; Greenblatt DJ
    Pharmacology; 1986; 32(4):226-31. PubMed ID: 3714804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer.
    Stuart-Harris R; Bradbrook I; Morrison P; Smith IE; Rogers HJ
    Br J Cancer; 1985 Apr; 51(4):485-92. PubMed ID: 3978028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced metabolism.
    Goss PE; Jarman M; Griggs LJ
    Br J Cancer; 1985 Feb; 51(2):259-62. PubMed ID: 3838134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women.
    Groen K; Horan MA; Roberts NA; Gulati RS; Miljkovic B; Jansen EJ; Paramsothy V; Breimer DD; van Bezooijen CF
    Clin Pharmacokinet; 1993 Aug; 25(2):136-44. PubMed ID: 8403737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of antipyrine and theophylline metabolism in man: molecular and clinical implications.
    Vesell ES
    Xenobiotica; 1986 May; 16(5):401-20. PubMed ID: 3739366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism.
    Dahlqvist R; Bertilsson L; Birkett DJ; Eichelbaum M; Säwe J; Sjöqvist F
    Clin Pharmacol Ther; 1984 Jun; 35(6):815-21. PubMed ID: 6734034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer.
    Lønning PE; Ueland PM; Kvinnsland S
    Cancer Chemother Pharmacol; 1986; 17(2):177-81. PubMed ID: 3719899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglutethimide in advanced breast cancer: plasma levels and clinical results after low and high doses.
    Strocchi E; Camaggi CM; Martoni A; Cellerino R; Miseria S; Malacarne P; Indelli M; Balli M; Bonciarelli G; Ambroso G
    Cancer Chemother Pharmacol; 1991; 27(6):451-5. PubMed ID: 2013115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cimetidine and ranitidine on hepatic drug metabolism.
    Breen KJ; Bury R; Desmond PV; Mashford ML; Morphett B; Westwood B; Shaw RG
    Clin Pharmacol Ther; 1982 Mar; 31(3):297-300. PubMed ID: 6120774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose and steady-state pharmacokinetics of aminoglutethimide.
    Lønning PE; Schanche JS; Kvinnsland S; Ueland PM
    Clin Pharmacokinet; 1985; 10(4):353-64. PubMed ID: 4042517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of capsaicin on the pharmacokinetics of antipyrine, theophylline and quinine in rats.
    Wanwimolruk S; Nyika S; Kepple M; Ferry DG; Clark CR
    J Pharm Pharmacol; 1993 Jul; 45(7):618-21. PubMed ID: 8105056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.